KK
Kalyani Kaduba Kale
About Kalyani Kaduba Kale
Data last updated:
Kalyani Kaduba Kale was a Director at Bravax Pharma Private Limited (2021–2023) and Director at Oncotek Pharma Private Limited (from 2019). The companies operate in Healthcare.
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Bravax Pharma Private Limited U51900MH2021PTC372965 | Director | 08 Dec 2021 | 2021 | ₹67.7 Lakh (FY 2025) | Active |
| Oncotek Pharma Private Limited U51909PN2019PTC187944 | Director | 22 Nov 2019 | 2019 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Kalyani Kaduba Kale
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Kalyani Kaduba Kale
Kalyani Kaduba Kale was first appointed on 22 Nov 2019 as Director at Oncotek Pharma Private Limited. The most recent appointment on record is 08 Dec 2021 at Bravax Pharma Private Limited.
Kalyani Kaduba Kale held 2 earlier board appointments: Bravax Pharma Private Limited (Director, 08 Dec 2021 to 02 Jun 2023); Oncotek Pharma Private Limited (Director, from 22 Nov 2019).